Comparing structural fingerprints using a literature-based similarity benchmark
暂无分享,去创建一个
[1] J. Hieble,et al. alpha-Adrenergic agents. 2. Synthesis and alpha 1-agonist activity of 2-aminotetralins. , 1982, Journal of medicinal chemistry.
[2] Peter Willett,et al. The use of 2D fingerprint methods to support the assessment of structural similarity in orphan drug legislation , 2014, Journal of Cheminformatics.
[3] Peter Willett,et al. Analysis of Data Fusion Methods in Virtual Screening: Similarity and Group Fusion , 2006, J. Chem. Inf. Model..
[4] Eric Jones,et al. SciPy: Open Source Scientific Tools for Python , 2001 .
[5] Robert D Clark,et al. Neighborhood behavior: a useful concept for validation of "molecular diversity" descriptors. , 1996, Journal of medicinal chemistry.
[6] J. Defalco,et al. 5-benzyloxytryptamine as an antagonist of TRPM8. , 2010, Bioorganic & medicinal chemistry letters.
[7] Lazaros Mavridis,et al. Comprehensive Comparison of Ligand-Based Virtual Screening Tools Against the DUD Data set Reveals Limitations of Current 3D Methods , 2010, J. Chem. Inf. Model..
[8] Jürgen Bajorath,et al. Similarity searching , 2011 .
[9] Prasenjit Mukherjee,et al. An overview of molecular fingerprint similarity search in virtual screening , 2016, Expert opinion on drug discovery.
[10] Christopher I. Bayly,et al. Evaluating Virtual Screening Methods: Good and Bad Metrics for the "Early Recognition" Problem , 2007, J. Chem. Inf. Model..
[11] S. Holm. A Simple Sequentially Rejective Multiple Test Procedure , 1979 .
[12] Gerald M. Maggiora,et al. On Outliers and Activity Cliffs-Why QSAR Often Disappoints , 2006, J. Chem. Inf. Model..
[13] M. Feth,et al. 5-Substituted 1H-pyrrolo[3,2-b]pyridines as inhibitors of gastric acid secretion. , 2008, Bioorganic & medicinal chemistry.
[14] Pekka Tiikkainen,et al. Critical Comparison of Virtual Screening Methods against the MUV Data Set , 2009, J. Chem. Inf. Model..
[15] P. Willett,et al. Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structures. , 2004, Organic & biomolecular chemistry.
[16] Dragos Horvath,et al. Neighborhood Behavior of in Silico Structural Spaces with Respect to in Vitro Activity Spaces-A Novel Understanding of the Molecular Similarity Principle in the Context of Multiple Receptor Binding Profiles , 2003, J. Chem. Inf. Comput. Sci..
[17] B. Roth,et al. SAR of psilocybin analogs: discovery of a selective 5-HT 2C agonist. , 2005, Bioorganic & Medicinal Chemistry Letters.
[18] George Papadatos,et al. The ChEMBL bioactivity database: an update , 2013, Nucleic Acids Res..
[19] E. Demont,et al. Evaluation of basic, heterocyclic ring systems as templates for use as potassium competitive acid blockers (pCABs). , 2009, Bioorganic & medicinal chemistry letters.
[20] Visakan Kadirkamanathan,et al. Analysis of Neighborhood Behavior in Lead Optimization and Array Design , 2009, J. Chem. Inf. Model..
[21] B. Andersson,et al. Antiulcer agents. 5. Inhibition of gastric H+/K(+)-ATPase by substituted imidazo[1,2-a]pyridines and related analogues and its implication in modeling the high affinity potassium ion binding site of the gastric proton pump enzyme. , 1991, Journal of medicinal chemistry.
[22] Luhua Lai,et al. Optimization of 5-hydroxytryptamines as dual function inhibitors targeting phospholipase A2 and leukotriene A4 hydrolase. , 2013, European journal of medicinal chemistry.
[23] Robert P. Sheridan. Alternative Global Goodness Metrics and Sensitivity Analysis: Heuristics to Check the Robustness of Conclusions from Studies Comparing Virtual Screening Methods , 2008, J. Chem. Inf. Model..
[24] Luc Patiny,et al. Wikipedia Chemical Structure Explorer: substructure and similarity searching of molecules from Wikipedia , 2015, Journal of Cheminformatics.
[25] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[26] Peter Gedeck,et al. QSAR - How Good Is It in Practice? Comparison of Descriptor Sets on an Unbiased Cross Section of Corporate Data Sets , 2006, J. Chem. Inf. Model..
[27] G. L. Grunewald,et al. Binding requirements of phenolic phenylethylamines in the benzonorbornene skeleton at the active site of phenylethanolamine N-methyltransferase. , 1986, Journal of medicinal chemistry.
[28] Pierre Baldi,et al. Large scale study of multiple-molecule queries , 2009, J. Cheminformatics.
[29] Woody Sherman,et al. Large-Scale Systematic Analysis of 2D Fingerprint Methods and Parameters to Improve Virtual Screening Enrichments , 2010, J. Chem. Inf. Model..
[30] Kathrin Heikamp,et al. Large-Scale Similarity Search Profiling of ChEMBL Compound Data Sets , 2011, J. Chem. Inf. Model..
[31] G. L. Grunewald,et al. Conformationally restricted and conformationally defined tyramine analogues as inhibitors of phenylethanolamine N-methyltransferase. , 1989, Journal of medicinal chemistry.
[32] Sebastian G. Rohrer,et al. Maximum Unbiased Validation (MUV) Data Sets for Virtual Screening Based on PubChem Bioactivity Data , 2009, J. Chem. Inf. Model..
[33] Andreas Bender,et al. How Similar Are Similarity Searching Methods? A Principal Component Analysis of Molecular Descriptor Space , 2009, J. Chem. Inf. Model..
[34] M. Feth,et al. Preparation of tetrahydroimidazo[2,1-a]isoquinolines and their use as inhibitors of gastric acid secretion. , 2007, Bioorganic & medicinal chemistry.
[35] Ramaswamy Nilakantan,et al. Topological torsion: a new molecular descriptor for SAR applications. Comparison with other descriptors , 1987, J. Chem. Inf. Comput. Sci..
[36] R. Venkataraghavan,et al. Atom pairs as molecular features in structure-activity studies: definition and applications , 1985, J. Chem. Inf. Comput. Sci..
[37] Woody Sherman,et al. Analysis and comparison of 2D fingerprints: insights into database screening performance using eight fingerprint methods , 2010, J. Cheminformatics.
[38] V. Setola,et al. Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agents. , 2012, Bioorganic & medicinal chemistry.
[39] A. Robertson,et al. Synthesis and SAR study of 4-arylpiperidines and 4-aryl-1,2,3,6-tetrahydropyridines as 5-HT₂C agonists. , 2012, Bioorganic & medicinal chemistry letters.
[40] Thierry Kogej,et al. Comparison of Molecular Fingerprint Methods on the Basis of Biological Profile Data , 2009, J. Chem. Inf. Model..
[41] Marvin Johnson,et al. Concepts and applications of molecular similarity , 1990 .
[42] C. Seyfried,et al. 5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressants. , 2000, Journal of medicinal chemistry.
[43] Adrià Cereto-Massagué,et al. Molecular fingerprint similarity search in virtual screening. , 2015, Methods.
[44] U. Lessel,et al. In vitro and in silico affinity fingerprints: Finding similarities beyond structural classes , 2000 .
[45] Peter Willett,et al. The Calculation of Molecular Structural Similarity: Principles and Practice , 2014, Molecular informatics.
[46] Sereina Riniker,et al. Open-source platform to benchmark fingerprints for ligand-based virtual screening , 2013, Journal of Cheminformatics.
[47] G. Maggiora,et al. Molecular similarity in medicinal chemistry. , 2014, Journal of medicinal chemistry.
[48] Robert P. Sheridan,et al. Comparison of Topological, Shape, and Docking Methods in Virtual Screening , 2007, J. Chem. Inf. Model..
[49] J. Hieble,et al. α‐ADRENERGIC AGENTS. 2. SYNTHESIS AND α1‐AGONIST ACTIVITY OF 2‐AMINOTETRALINS , 1982 .
[50] J. Irwin,et al. Benchmarking sets for molecular docking. , 2006, Journal of medicinal chemistry.
[51] L. Hedstrom,et al. Triazole inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase. , 2009, Journal of medicinal chemistry.
[52] B. Costall,et al. Synthesis and dopaminergic properties of some exo- and endo-2-aminobenzonorbornenes designed as rigid analogue of dopamine. , 1982, Journal of medicinal chemistry.